NEW YORK (GenomeWeb News) — Bioneer will exclusively distribute and market Sequenom’s genetic analysis products in South Korea, the firms said today.
 
Under a separate agreement, Bioneer will also operate a core facility that will provide contract services for human, livestock, and agricultural applications throughout South Korea using Sequenom's MassARRAY system and consumable products, the partners said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.